Mikhail Ovanesov

Dr. Ovanesov is a Research Biologist and Principal Investigator in the Office of Tissues and Advanced Therapies at CBER, FDA. He graduated from the Moscow Institute of Physics and Technology and received his Ph.D. degree in Biology from the Russian Academy of Medical Sciences. Prior to joining the FDA, Dr. Ovanesov completed postdoctoral fellowships with the American Red Cross in Rockville, MD, Johns Hopkins University Medical School in Baltimore, MD, and Janelia Farm Research Campus of the Howard Hughes Medical Institutes in Ashburn, VA. Dr. Ovanesov participates in the review of plasma-derived and recombinant plasma protein concentrates, transfusion products including frozen and dried plasma and platelets, and gene therapies for hemophilia. His research laboratory investigates the mechanisms of action of procoagulant therapeutics and participates in international collaborative studies on international standards for coagulation factor activity.